Cargando…
Lessons Learned from Targeting IGF-I Receptor in Thyroid-Associated Ophthalmopathy
Complex immunological mechanisms underlie the pathogenesis of thyroid-associated ophthalmopathy (TAO). Historical models of Graves’ disease and TAO have focused almost entirely on autoimmune reactivity directed against the thyrotropin receptor (TSHR). The insulin-like growth factor-I receptor (IGF-I...
Autores principales: | Janssen, Joseph A.M.J.L., Smith, Terry J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917650/ https://www.ncbi.nlm.nih.gov/pubmed/33673340 http://dx.doi.org/10.3390/cells10020383 |
Ejemplares similares
-
Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy
por: Smith, Terry J., et al.
Publicado: (2017) -
It Takes Two to Tango: IGF-I and TSH Receptors in Thyroid Eye Disease
por: Girnita, Leonard, et al.
Publicado: (2022) -
New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor
por: Smith, Terry J
Publicado: (2018) -
Teprotumumab as a Novel Therapy for Thyroid-Associated Ophthalmopathy
por: Smith, Terry J.
Publicado: (2020) -
New Insights from IGF-IR Stimulating Activity Analyses: Pathological Considerations †
por: Janssen, Joseph A.M.J.L.
Publicado: (2020)